Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing CAR macrophages, a disruptive immunotherapy. Our technology leverages advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cell therapy for the treatment of human diseases.